Test Price
2,800 AED✅ Home Collection Available
COL17A1 Gene Epidermolysis Bullosa, Junctional Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين COL17A1 للكشف عن انحلال البشرة الفقاعي الوصلي بتقنية NGS في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
الملخص التنفيذي
يُقدم تحليل جين COL17A1 بتقنية التسلسل الجيني الشامل (NGS) أعلى معايير الدقة التشخيصية (99.9%) وفق توجيهات هيئة الصحة بدبي لعام 2026، ويشمل جلسة إرشاد وراثي، خدمة سحب منزلي معتمدة بسلسلة تبريد، وإرشاد سريري هاتفي بعد النتائج. السعر 2800 درهم إماراتي مع إمكانية التحقق المباشر من التغطية التأمينية عبر الواتساب.
Regulatory Compliance: This service strictly adheres to UAE Federal Decree-Law No. 41 of 2024 (Art. 87), the CDS Law 2026 on Minors, and the UAE Personal Data Protection Law (PDPL). All genetic data is processed with full legal and ethical safeguards.
Overview: COL17A1 Gene & Junctional Epidermolysis Bullosa
This comprehensive genetic test sequences the entire COL17A1 gene using Next-Generation Sequencing (NGS) to diagnose junctional epidermolysis bullosa (JEB), a life-threatening inherited skin fragility disorder. Designed for dermatologists, clinical geneticists, and pediatricians, the test confirms the molecular diagnosis, guides wound care and nutritional management, and enables precise family genetic counselling.
| Feature | Our COL17A1 NGS Test | Standard Sanger Sequencing |
|---|---|---|
| Technology | NGS (Full Gene Coverage) | Targeted Mutation Analysis |
| Diagnostic Sensitivity | 99.9% | ~85% (limited variants) |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Price (AED) | 2800 | 2000 (approx.) |
| Accreditation | ISO 9001:2015, DHA 2026 | Variable |
Physician Insight & Safety Protocol
“As a DHA-licensed clinical specialist, I underscore that this NGS test is a powerful diagnostic breakthrough, yet it must be interpreted alongside the patient’s full clinical picture and family history. We urge all families to engage in genetic counselling to comprehend the implications fully. Do not discontinue any prescribed wound care or therapy without consulting your managing physician.”
– Dr. PRABHAKAR REDDY, DHA License No. 61713011.
⚠️ Important Medication Notice:
Do not discontinue prescribed medication or treatments, including topical antibiotics, pain relievers, or nutritional supplements, without consulting your doctor. Genetic testing does not replace ongoing clinical management.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Individuals without a clinical suspicion of junctional EB or a confirmed family history of COL17A1-related disorders; self-testing on asymptomatic minors without a paediatric geneticist referral (per UAE CDS Law 2026).
- ER Red Flags: Rapidly spreading blisters, signs of sepsis (fever, lethargy), severe oral or oesophageal blistering causing difficulty swallowing or breathing, or acute respiratory distress. Seek immediate emergency care.
Patient FAQ & Clinical Guidance
What is the accuracy of the COL17A1 NGS test for diagnosing junctional EB?
Our NGS test achieves 99.9% diagnostic sensitivity by sequencing all coding exons and splice junctions of the COL17A1 gene, providing near-definitive confirmation of pathogenic variants.
يحقق اختبار التسلسل الجيني NGS لدينا حساسية تشخيصية تصل إلى 99.9% عبر فحص جميع الإكسونات والوصلات الجينية، مما يمنح تأكيداً شبه قاطع للطفرات المسببة للمرض.
How long does it take to receive the test result and what does the process involve?
Results are delivered within 3 to 4 weeks, covering DNA extraction, NGS library preparation, bioinformatics analysis, and a comprehensive clinical report by a multidisciplinary team.
تُسلّم النتائج خلال 3 إلى 4 أسابيع بعد استخراج الحمض النووي، وتحضير المكتبة الجينية، وتحليل المعلوماتية الحيوية، وتقرير سريري شامل من فريق متعدد التخصصات.
Is this covered by health insurance in the UAE, and how can I verify?
Most UAE insurance plans cover genetically indicated diagnostic tests like COL17A1 sequencing when prescribed by a dermatologist or geneticist; direct billing verification is available via WhatsApp at +971545488731 before sample collection.
تغطي معظم خطط التأمين في الإمارات الفحوصات الجينية المشخّصة مثل تحليل COL17A1 عند وصفها من طبيب مختص؛ يمكن التحقق المباشر عبر واتساب على الرقم +971545488731 قبل سحب العينة.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians